EUVIMEDEUVIMED entdecken
Crossref

Hypomanic symptoms in major depressive disorder: Prognostic impact and treatment issues

Paolo Olgiati, Siegfried Kasper, Joseph Zohar, Daniel Souery, Stuart Montgomery, Panagiotis Ferentinos, Dan Rujescu, Raffaella Zanardi, Gernot Fugger, Raffaele Ferri, Mariangela Tripodi, Bernhard T Baune und 3 weitere

Journal of Affective Disorders · 2025

DOI: 10.1016/j.jad.2024.10.104 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Affective Disorders, 2025. Verfasst von Paolo Olgiati und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Sciences of Public Health and Paediatrics, University of Turin, Turin, Italy; Department of Psychiatry ASLTO4, Turin, Italy. Hauptthemen laut MEDLINE: Major Depressive Disorder, Suicidal Ideation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 85 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Mixed depression (MXD), defined as (hypo)manic symptoms occurring within major depressive episodes, is common in both bipolar and unipolar disorders, but its prognostic and treatment implications remain unclear. This study aimed to examine the relationship between hypomanic symptoms, treatment response and remission of suicidal thoughts. METHODS: We analyzed 1243 adults with major depressive disorder (MDD), recruited for a naturalistic study on treatment-resistant depression. Data were gathered cross-sectionally and retrospectively through structured interviews and clinical rating scales including the Young Mania Rating Scale (YMRS) and Montgomery-Asberg Depression Rating Scale (MADRS); statistical analyses were performed using univariate and multivariate methods. RESULTS: Hypomanic symptoms were present in 651 patients (45 %), while 307 patients (25 %) responded to treatment. Both treatment responders (p < 0.0001) and those who achieved remission from suicide ideation (p = 0.0085) showed lower hypomanic (YMRS) scores. Multivariate analysis showed that hypomanic symptoms were negatively linked to treatment response (O.R. 0.71-0.87), while bipolar spectrum markers such as age at illness onset (O.R. 1.00-1.03) and MDD recurrence (O.R. 0.47-0.89) predicted remission from suicidal thoughts. Medications commonly used to treat bipolar disorder showed some benefits, with dopamine/serotonin antagonists improving suicide ideation (p < 0.0001) and mood stabilizers being associated with reduced hypomanic symptoms (p = 0.0003). LIMITATIONS: The study lacked prospective clinical assessments and treatment randomization. CONCLUSION: Hypomanic symptoms are common in unipolar depression; their assessment is essential to identify challenging-to-treat cases and select the best pharmacological options.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Major Depressive DisorderSuicidal IdeationHumansFemaleMaleAdultMiddle AgedPrognosisRetrospective StudiesCross-Sectional StudiesManiaPsychiatric Status Rating ScalesAntidepressive AgentsDepressive Disorder, Treatment-ResistantBipolar DisorderTreatment Outcome

Stichwörter der Autor:innen

Antidepressant responseHypomanic symptomsMajor depressive disorderMood stabilizersTreatment-resistant depressionUnipolar depression

Substanzen

Antidepressive Agents

Autor:innen und Institutionen

  • Department of Sciences of Public Health and Paediatrics, University of Turin, Turin, Italy; Department of Psychiatry ASLTO4, Turin, Italy.
  • Department of Psychiatry and Psychotherapy, Medical University Vienna, Vienna, Austria; Center for Brain Research, Department of Molecular Neuroscience, Medical University Vienna, Vienna, Austria.
  • Department of Psychiatry, Sheba Medical Center, Tel Hashomer, and Sackler School of Medicine, Tel Aviv University, Israel.
  • Psy Pluriel - Epsylon caring for mental health Brussels and Laboratoire de Psychologie Médicale, Université libre de Bruxelles, Belgium.
  • Imperial College School of Medicine, London, UK.
  • Department of Psychiatry, Athens University Medical School, Athens, Greece.

Zitieren

APA

Olgiati, P., Kasper, S., Zohar, J., Souery, D., Montgomery, S., Ferentinos, P., Rujescu, D., Zanardi, R., Fugger, G., Ferri, R., Tripodi, M., Baune, B. T., Fabbri, C., Mendlewicz, J., & Serretti, A. (2025). Hypomanic symptoms in major depressive disorder: Prognostic impact and treatment issues. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2024.10.104

Vancouver

Olgiati P, Kasper S, Zohar J, Souery D, Montgomery S, Ferentinos P, et al. Hypomanic symptoms in major depressive disorder: Prognostic impact and treatment issues. Journal of Affective Disorders. 2025. doi:10.1016/j.jad.2024.10.104

BibTeX
@article{Olgiati2025,
  author = {Olgiati, Paolo and Kasper, Siegfried and Zohar, Joseph and Souery, Daniel and Montgomery, Stuart and Ferentinos, Panagiotis and Rujescu, Dan and Zanardi, Raffaella and Fugger, Gernot and Ferri, Raffaele and Tripodi, Mariangela and Baune, Bernhard T and Fabbri, Chiara and Mendlewicz, Julien and Serretti, Alessandro},
  title = {Hypomanic symptoms in major depressive disorder: Prognostic impact and treatment issues},
  journal = {Journal of Affective Disorders},
  year = {2025},
  doi = {10.1016/j.jad.2024.10.104}
}
Kostenlos starten →